Corpay CPAY

Technology · Software - Infrastructure · Synthos Deep Dive · 2026-07-03

$407.88

Buy — Tactical

—

The Overview

Corpay (the company formerly called FLEETCOR) runs the payment plumbing that businesses use to pay for things — fuel and tolls for truck fleets, corporate bill-pay and virtual cards, cross-border payments, and hotel bookings for work travel. Every time a business swipes one of its cards or moves money through its system, Corpay takes a small cut. It does this millions of times a day, which is why it keeps about 73 cents of every sales dollar before other costs.

Unlike most fast-growing tech names, this one is not expensive. You are paying about 13 times next year's expected profit for a company growing profit at roughly 19% a year — that is a reasonable price, not a bubble price. Our verdict is Buy — Tactical: a decent risk/reward, but sized as a smaller "satellite" holding because no outside experts we track have weighed in, and there are real worries.

Here is what the three scores mean in everyday terms:

Downside Risk 5/10 (middle of the road). The stock is cheap and doesn't swing wildly, which is protective — but the company borrows a fair amount (2.7× its yearly cash earnings), its sales rise and fall with fuel prices and currencies, and the government's trade regulator (the FTC) is suing it.
Growth Quality 7/10 (good). Solid, steady, profitable growth with high returns — just not the explosive kind.
Exponential Potential 4/10 (modest). It should keep compounding at a healthy clip, but growth is slowly cooling, so don't expect it to double quickly.

The one big worry: an FTC lawsuit over how its fuel-card business discloses fees, plus the fact that a chunk of results depend on fuel prices and exchange rates the company can't control.

Putting a number on it: our fair-value estimate is $415 against a current price of $407.88 — real upside if our numbers are right.

Target entry zone $377 – $408 accumulate in this band; ideal adds on a dip toward the 50-day average near $377, keeping roughly a 2% margin below our $415 base-case fair value

Our summary metrics

Downside Risk (lower = safer)5/10Moderate

Cheap on forward earnings (13× FY26E adj) & low beta 0.87, but 2.7× leverage, an FTC suit, and fuel-price/FX cyclicality.

Growth Quality7/10High

~19% forward adj-EPS CAGR, 73% gross margin, 31% ROE, 11% durable organic growth — high quality, not hyper-growth.

Exponential Potential4/10Moderate

Steady mid-teens compounder that is gently decelerating; $23B cap leaves room but this is a compounder, not a multibagger.

Fair value$415 $270–$500

What does “fair value” mean?

Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.

The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.

What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)

Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.

Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.

WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.

HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.

AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

Exponential Potential

Exponential Potential4/10Moderate

Steady mid-teens compounder that is gently decelerating; $23B cap leaves room but this is a compounder, not a multibagger.

What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.

Deeper analysis

Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.

Check our number Market-implied growth ≈ 17%/yr This isn’t how we calculate fair value — it’s public math you can verify yourself. To justify today’s $408, earnings would have to compound roughly 17% a year for 10 years (9% discount rate). Analysts forecast ~16%/yr, so the market is pricing in about what the Street expects.

Reference table

Street consensus	$386 (high $450 / low $340; 13 Buy · 5 Hold · 0 Sell) — context, not our anchor
Valuation	23× trailing GAAP EPS · 13.2× FY26E adj · 11.5× FY27E adj · 9.9× FY28E adj · EV/S 5.1× · EV/EBITDA 9.6×
Technicals	Mild uptrend — $352, −3.2% off 52-wk high, above 50/200-DMA, RSI 51 (neutral), +4% 12-mo (SPY +21%)
Conviction	Moderate — 0 expert voices in the Synthos KB; this is a quant/fundamentals call, not a corroborated-panel call
Position sizing	Satellite/tactical, ~2–3% — value-compounder tilt, not a core conviction anchor

What the experts actually said

No independent expert claims in the Synthos knowledge base yet for CPAY — this dive is fundamentals- and technicals-driven, not panel-driven.

Price & moving averages 12 months · 50 & 200-day averages · 52-week range

Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.

Bollinger Bands 20-day average ± 2 standard deviations

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

RSI (14) momentum gauge · 0–100

Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 57.

MACD 12 / 26 / 9 · trend & momentum

The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.

Relative performance vs S&P 500 & its sector (XLK (sector)), set to 100 a year ago

Solid = CPAY · dashed = S&P 500 · dotted = XLK (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$407.88

Market cap$27B

P/E trailing23×

P/E FY26E / FY27E15× / 13×

EV / Salesn/a — vendor EV unreliable

EV / EBITDAn/a — vendor EV unreliable

Gross margin73.3%

Net margin22.7%

Dividend yield0.00%

Beta0.869

52-wk range$255 – $425

RSI(14)55

50 / 200-DMA$377 / $334

12-mo return+25% (SPY +19%)

Street target$446 ($388–$530)

Analyst grades14 Buy · 4 Hold · 0 Sell

FMP ratingB

Next earnings2026-08-05 (Q2'26 earnings; Street adj EPS est ~$6.56, mgmt guide ~$6.55)

EV multiples are withheld for this name: the vendor’s enterprise value differs from our own rebuild (market cap + total debt − cash − short-term investments) by more than 15%, so we do not know which is right. Rather than print a figure we cannot stand behind, we show none — the discussion in the body uses the corrected basis and says so.

1. What it is

Corpay, Inc. (NYSE: CPAY; renamed from FLEETCOR Technologies in March 2024) is an Atlanta-based global B2B fintech that provides corporate spend and payment solutions. Founded 1986, IPO'd 2010, ~11,200 employees, led by long-tenured founder-CEO Ronald F. Clarke. It earns money on transaction fees, interchange, spreads and float across three reporting segments. Fiscal year ends December 31.

Revenue mix (FY2025, from segment filings):

By segment: Vehicle Payments (fuel cards / fleet) $2,138.7M (47%) · Corporate Payments (AP automation, virtual cards, cross-border) $1,635.1M (36%) · Lodging $469.5M (10%). (Segment lines sum to ~$4.24B of the $4.53B total; the remainder is other/eliminations.) The growth engine is Corporate Payments, up ~34% YoY (FY24 $1,221.9M → FY25 $1,635.1M) and delivering 16% organic growth in Q1'26 per management.
By geography (largest disclosed): United States $2,204.6M · Brazil $713.3M · United Kingdom $642.3M (remainder spread across other international markets). Meaningfully more international than a typical US payments name — a diversification strength but also the source of the FX sensitivity.

The strategic story is a mix-shift away from the legacy, fuel-price-sensitive Vehicle business toward higher-growth Corporate Payments and cross-border, funded by heavy buybacks.

2. The expert thesis — (no expert coverage)

There is no expert coverage of CPAY in the Synthos knowledge base: total_claims = 0, breadth 0, net conviction 0. No net-bullish or cautionary voice we track has published a distilled, reconcilable claim on this name.

Per the House Standard, we do not manufacture conviction we do not have. This verdict is therefore entirely fundamentals- and quant-driven — built from the FMP financials, analyst estimates, management's own SEC-filed guidance (§9, half-weighted), and Synthos's scoring framework. Read it as a quantitative/valuation call, not as a corroborated-panel call like our conviction-track flagships. Where a name like this carries no independent expert signal, we deliberately cap conviction at Moderate and size it as a satellite (§12).

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

Score	0–10	The read
Downside Risk (lower = safer)	5 · Moderate	Genuinely cheap on forward earnings (13.2× FY26E adj, EV/EBITDA 9.6×) and beta 0.87 cushion the downside — but management-basis leverage is 2.7×, a live FTC lawsuit hangs over the fuel-card business, and revenue flexes with fuel prices, FX and rates.
Growth Quality	7 · Good	~19% forward adj-EPS CAGR, 73% gross margin, 31% ROE, 17.6% ROCE, and a durable 11% organic rate for four straight quarters. High quality — just not hyper-growth, and returns lean on leverage.
Exponential Potential	4 · Modest	Steady compounder that is gently decelerating (organic ~11%, headline aided by M&A/fuel). $23B cap leaves TAM room, but this is a compounder, not a multibagger.

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them.

Case	Key assumptions	Fair value
Bull	Corporate Payments & cross-border keep compounding mid-teens organic; fuel/FX tailwinds; buybacks shrink the count toward ~64M. FY27E adj EPS beats to ~$32 (vs ~$30.7 cons); multiple re-rates to ~15.5×.	~$500 (+42%)
Base (our anchor)	Estimates roughly hit — FY27E adj EPS ~$30.7; a durable high-quality mid-teens compounder earns a modest re-rate to ~13.5×.	~$415 (+18%)
Bear	FTC ruling bites, fuel prices/FX turn against them, organic growth slips to high-single-digits; multiple stays depressed. FY27E adj EPS misses to ~$27; multiple ~10×.	~$270 (−23%)

Synthos fair value = the base case, ~$415 (+18%), with the full $270–$500 span as the honest range. This anchor sits above the Street's $386 consensus (we credit the forward earnings power at a still-undemanding multiple) while the bear is below the Street's $340 low (we take the FTC/cyclicality risk seriously). This is a tracked call — the Forecaster Scorecard grades it once it matures. Note the multiples here are on adjusted EPS; on GAAP FY25 EPS ($15.03) the same prices imply higher headline multiples.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers-from-here). CPAY is a solid compounder, not an exponential:

Forward growth: revenue CAGR FY25→FY28E ~12% ($4.53B → $6.37B); adjusted-EPS CAGR ~19% ($21.28 FY25E adj → $35.67 FY28E), with buybacks doing part of the per-share lift.
Acceleration (2nd derivative) is mildly negative: organic revenue growth has held at 11% for four consecutive quarters — steady, not accelerating — while headline growth (25% in Q1'26) is flattered by acquisitions and fuel prices. Adj-EPS growth is decelerating from ~29% (Q1'26 YoY) toward the high-teens as comps normalize. Per our flagship philosophy we favor forward next-exponentials; CPAY sits firmly on the compounder end.
Room to run: the global B2B/commercial-payments TAM is large ($100B+ across AP automation and cross-border), and Corporate Payments is under-penetrated, so demand runway is real. But at $23B the name is not tiny, and the legacy Vehicle segment (47% of revenue) is a low-growth, fuel-price-tethered anchor.
Reinvestment runway: capital allocation is tilted to buybacks (>$780M repurchased in Q1'26 alone) and tuck-in M&A rather than organic capacity — a per-share compounding model, not a reinvest-for-hyper-growth model.

Exponential Potential: Modest (4/10). Own it for durable ~15–19% per-share compounding at a fair price, not for a fast multibagger. The decelerating-organic profile and fuel/FX ballast are exactly why it scores below the midpoint.

5. Financials (real numbers — FMP annual/quarterly)

Revenue: FY25 $4.528B, +13.9% (FY24 $3.975B, +5.8% on FY23 $3.758B). Q1'26 $1.261B, +25.4% YoY (headline boosted by M&A/fuel; 11% organic per management).
Quarterly trajectory: Q1'25 $1.006B → Q2 $1.102B → Q3 $1.172B → Q4 $1.248B → Q1'26 $1.261B. Steady sequential grind.
Margins: gross 72.8% TTM, EBITDA 53.4% TTM, operating ~43%, net 24.6% TTM. High-margin, asset-light transaction economics.
Earnings: FY25 net income $1.070B, GAAP diluted EPS $15.03 (adjusted ~$21.28 per consensus). Q1'26 net income $350M (diluted EPS $5.07) — but ~$1.19/sh was a one-time gain on a business sale; adjusted Q1'26 EPS was $5.80 (+29% YoY).
Cash flow: FY25 operating CF $1.50B, capex −$201M, FCF ~$1.30B (FCF yield ~5.7%). FCF is directed to buybacks and debt paydown.
Balance sheet — read carefully: FMP shows FY25 cash of $8.99B and net debt of only $1.12B (net-debt/EBITDA 0.60× TTM), but that cash largely reflects customer/float and restricted balances, not free corporate cash. Management's own leverage figure is 2.7× (Q1'26). We anchor to management's 2.7× as the honest gauge — total debt is ~$10.1B and interest expense ran ~$404M in FY25. Treat the headline 0.60× as misleadingly low.

6. Valuation — priced in or room?

CPAY is one of the more reasonably priced quality names in the pool. On adjusted consensus the forward P/E is 13.2× (FY26E) → 11.5× (FY27E) → 9.9× (FY28E) — undemanding for a mid-teens organic grower with 73% gross margins and 31% ROE. On trailing GAAP EPS ($15.03) it is ~23×; EV/EBITDA is 9.6× and EV/S 5.1×. The gap between the cheap forward-adjusted multiple and the fuller GAAP/EV multiples is the tension: the bull pays 13× forward and waits for compounding; the skeptic notes GAAP earnings are lower than adjusted, leverage is 2.7×, and an FTC overhang caps the multiple. A modest re-rate to ~13.5× FY27E adj EPS underpins our $415 base case. Street targets (context): consensus $386, high $450, low $340 — our base sits just above consensus. This is a quality-compounder-at-a-fair-price call, not a deep-value or a momentum call.

7. Technicals (from the tech block)

Trend: mildly up. $352 sits above the 50-DMA ($338) and 200-DMA ($313), and the 50 is above the 200 (golden-cross posture). MACD −0.74 (marginally negative — momentum cooling).
Location: −3.2% off the 52-week high ($364), +38% off the 52-week low ($255); max drawdown from peak a modest −9.5%.
Momentum: RSI(14) 51 — dead neutral, neither overbought nor oversold. No stretched entry.
Relative strength (the tell): +4.0% 12-mo vs SPY +20.6% and QQQ +30.3% — a notable laggard over the year — but +21.7% 3-mo vs SPY +13.7% shows recent catch-up. The 12-month underperformance is part of why the valuation is undemanding.
Read: technicals are constructive but not urgent — a healthy uptrend off the lows with neutral momentum. No technical reason to chase; scaling in near the rising 50-DMA (~$338) is the lower-risk entry.

8. Moat & competitive position

Corpay's moat is network scale and switching costs in closed-loop B2B payment networks: entrenched fuel-card acceptance networks, deep AP/ERP integrations in Corporate Payments, and cross-border rails that are operationally hard and regulation-heavy to replicate. The 73% gross margin and 31% ROE evidence real pricing power. The weaknesses: the legacy Vehicle segment is exposed to fuel-price cycles and long-run EV adoption, interchange/fee economics face regulatory scrutiny (the FTC suit targets fuel-card fee disclosure), and cross-border is competitive.

Peer set (FMP-provided, market cap): F5 $23.0B, Kaspi.kz $17.1B, Toast $16.7B, Gen Digital $16.1B, Jacobs $15.1B, CGI $14.4B, Check Point $14.2B, Nutanix $13.9B, GoDaddy $11.7B, Gartner $9.1B. (Note: FMP's "Software — Infrastructure" peer list is a poor functional match — the truer comps are payments/fintech names like WEX, FIS, Fiserv, Global Payments and Visa/Mastercard, which are not in the supplied set. Treat this peer table as a size cohort, not a business comp.)

9. Management, capital allocation & guidance

Management: founder-CEO Ron Clarke (in the seat since 2000) is a long-tenured, disciplined operator with a strong per-share-value track record (aggressive buybacks over a decade). CFO Peter Walker.
Capital allocation: buyback-led — 2.4M shares / $786M repurchased in Q1'26, count trending toward ~67M diluted; FCF also used to pay down debt; no dividend. Tuck-in M&A supplements organic growth. Appropriate given the high ROE, though it does rely on leverage.
Insider activity: the most recent Form 4 cluster (2026-06-15, Group President Brazil & US Vehicle Payments) is option exercises with a ~$786K sale at ~$352 — routine exercise-and-sell, not a discretionary red-flag cluster.
Management's own guidance (half-weighted — their self-interested words): from the 2026-05-07 Q1 earnings release (SEC 8-K, EX-99.1), management raised FY2026 guidance: revenue $5.250–5.330B, GAAP net income $1.352–1.432B, adjusted EPS $26.30–27.10, on assumptions of ~$4.17/gal US fuel, flat fuel spreads, FX unchanged from February, interest expense $415–445M, ~67M diluted shares, and a 25–27% adjusted tax rate. Q2'26 guide: revenue ~$1.295B (+18% YoY), adjusted EPS ~$6.55 (+28% YoY). This is management talking its own book (half-weight), but it is specific, dated and internally consistent with the estimates — and explicitly flags fuel/FX/rate dependence.

10. Catalysts & what to watch

Next earnings: 2026-08-05 (Q2'26; management guide revenue ~$1.295B, adj EPS ~$6.55; Street ~$6.56). The key lines: Corporate Payments organic growth (was 16%) and whether total organic holds at ~11%.
FTC litigation: any ruling, settlement or injunction on the fuel-card fee-disclosure suit — the single biggest discrete overhang.
Fuel prices & FX: management's guide assumes ~$4.17/gal and February FX; deviations move both revenue and the stock.
Corporate Payments / cross-border mix-shift: continued share gains here are the multi-year re-rating thesis.
Buyback pace & leverage: share-count reduction vs the 2.7× leverage line.

Thesis tripwires (what would change the call): organic growth slipping below ~8% for two quarters; an adverse FTC outcome with real economic teeth; leverage rising above ~3.5×; or adjusted EPS guidance cut.

11. Key risks

FTC lawsuit (structural/legal): the company's own forward-looking statements name a pending FTC lawsuit (fuel-card fee disclosure) — an overhang on both the multiple and the Vehicle segment's economics.
Cyclicality: results flex with fuel prices, fuel-price spreads, FX rates and interest rates — management's guidance is explicitly assumption-dependent on all four.
Leverage: 2.7× management-basis leverage with ~$404M annual interest expense; a rate or earnings shock is amplified. (The 0.60× FMP net-debt/EBITDA is misleading — see §5.)
Secular EV risk: long-run electric-vehicle adoption erodes the legacy fuel-card volume base (47% of revenue).
No expert corroboration: unlike our conviction-track names, zero independent expert voices back this thesis — it rests entirely on quant/fundamentals, so treat conviction as Moderate.
Adjusted-vs-GAAP gap: the attractive multiple is on adjusted EPS; GAAP earnings are meaningfully lower (Q1'26 included a $1.19/sh one-time gain).

12. Verdict, position sizing & monitoring

Buy — Tactical. CPAY is a genuinely high-quality B2B payments compounder — 73% gross margin, 31% ROE, 11% durable organic growth, founder-led, buyback-disciplined — trading at only ~13× forward adjusted earnings with management raising guidance. The base-case fair value of ~$415 (+18%) rests on the modest assumption that management keeps executing at a slightly re-rated but still-undemanding multiple. What holds it back from Core status: no expert corroboration in our KB, a live FTC suit, 2.7× leverage, and real fuel/FX/rate cyclicality — so we cap conviction at Moderate and size it as a satellite.

Sizing: tactical/satellite, ~2–3% — a value-compounder tilt to own, not a core anchor. Scale in near the rising 50-DMA (~$338) rather than chasing.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print. Logged as a tracked Synthos call as of 2026-07-03 at $352.46.
Single biggest risk: the FTC lawsuit combined with fuel-price/FX cyclicality on a 2.7×-levered balance sheet.

Provenance & disclosures

Traceability: 0 KB claims — this is a fundamentals/quant call with no expert corroboration; there is no conviction to fabricate. Every number cited traces to the FMP data pull or management's SEC-filed release.
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · management guidance from the 2026-05-07 8-K. Forward figures are analyst consensus (FMP) or management guidance, labeled as estimates.
Management caveat: FY26/Q2'26 guidance is management's own book, half-weighted by design.
Adjusted vs GAAP: forward P/E multiples use adjusted consensus EPS; trailing GAAP EPS is $15.03. Leverage is stated on management's 2.7× basis, not FMP's float-inflated 0.60×.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").